Identifying The Optimal Therapeutic Applications for Your Inflammasome Inhibitor – Avoid InfiniteThink!

Time: 9:00 am
day: Day Two


  • Therapeutic options for inflammasome inhibitors seem infinite – this presentation will address key considerations for narrowing the list to those with the highest potential for clinical and commercial success
  • Disease pathogenesis
  • Models for preclinical proof-of-concept
  • Unmet medical and patient needs
  • Differentiation from current and pipeline competitors